{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:40:23Z","timestamp":1772271623847,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,14]]},"DOI":"10.7759\/cureus.77434","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T11:12:09Z","timestamp":1736853129000},"source":"Crossref","is-referenced-by-count":1,"title":["Medicaid Expansion and Survival Outcomes Among Men With Prostate Cancer"],"prefix":"10.7759","author":[{"given":"Oluwasegun A","family":"Akinyemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojisola E","family":"Fasokun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Hercules","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayodeji","family":"Ikugbayigbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunice","family":"Odusanya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakin","family":"Hatcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluebubechukwu","family":"Eze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lerone","family":"Ainsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Micheal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kakra","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela W","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Prostate cancer statistics. (2024). Accessed. 2024: https:\/\/www.cdc.gov\/prostate-cancer\/statistics\/index.html."},{"key":"ref2","unstructured":"Key statistics for prostate cancer. (2024). Accessed. 2024: https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/about\/key-statistics.html."},{"key":"ref3","unstructured":"Prostate cancer treatment (PDQ\u00ae)-patient version. (2024). Accessed. 2024: https:\/\/www.cancer.gov\/types\/prostate\/patient\/prostate-treatment-pdq."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S83333","article-title":"Factors that influence patient preferences for prostate cancer management options: a systematic review","volume":"9","author":"Showalter TN","year":"2015","unstructured":"Showalter TN, Mishra MV, Bridges JF. Factors that influence patient preferences for prostate cancer management options: a systematic review. Patient Prefer Adherence. 2015, 9:899-911. 10.2147\/PPA.S83333","journal-title":"Patient Prefer Adherence"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-019-0258-3","article-title":"Financial toxicity associated with treatment of localized prostate cancer","volume":"17","author":"Imber BS","year":"2020","unstructured":"Imber BS, Varghese M, Ehdaie B, Gorovets D. Financial toxicity associated with treatment of localized prostate cancer. Nat Rev Urol. 2020, 17:28-40. 10.1038\/s41585-019-0258-3","journal-title":"Nat Rev Urol"},{"key":"ref6","unstructured":"Financial burden of cancer care. (2024). Accessed. 2024: https:\/\/progressreport.cancer.gov\/after\/economic_burden."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1460","article-title":"National and state estimates of lost earnings from cancer deaths in the United States","volume":"5","author":"Islami F","year":"2019","unstructured":"Islami F, Miller KD, Siegel RL, et al.. National and state estimates of lost earnings from cancer deaths in the United States. JAMA Oncol. 2019, 5:e191460. 10.1001\/jamaoncol.2019.1460","journal-title":"JAMA Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2013.04.001","article-title":"Molecular pathogenesis and progression of prostate cancer","volume":"40","author":"Schrecengost R","year":"2013","unstructured":"Schrecengost R, Knudsen KE. Molecular pathogenesis and progression of prostate cancer. Semin Oncol. 2013, 40:244-58. 10.1053\/j.seminoncol.2013.04.001","journal-title":"Semin Oncol"},{"key":"ref9","article-title":"Risk factors for prostate cancer","volume":"4","author":"Gann PH","year":"2002","unstructured":"Gann PH. Risk factors for prostate cancer. Rev Urol. 2002, 4:S3-S10.","journal-title":"Rev Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.prnil.2019.08.001","article-title":"A review of social determinants of prostate cancer risk, stage, and survival","volume":"8","author":"Coughlin SS","year":"2020","unstructured":"Coughlin SS. A review of social determinants of prostate cancer risk, stage, and survival. Prostate Int. 2020, 8:49-54. 10.1016\/j.prnil.2019.08.001","journal-title":"Prostate Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.50416","article-title":"Evaluation of social determinants of health and prostate cancer outcomes among black and white patients: a systematic review and meta-analysis","volume":"6","author":"Vince RA Jr","year":"2023","unstructured":"Vince RA Jr, Jiang R, Bank M, et al.. Evaluation of social determinants of health and prostate cancer outcomes among black and white patients: a systematic review and meta-analysis. JAMA Netw Open. 2023, 6:e2250416. 10.1001\/jamanetworkopen.2022.50416","journal-title":"JAMA Netw Open"},{"key":"ref12","unstructured":"Medicare and Medicaid Act (1965). (2024). Accessed. 2024: https:\/\/www.archives.gov\/milestone-documents\/medicare-and-medicaid-act."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201402-072PS","article-title":"Medicaid expansion under the Affordable Care Act. Implications for insurance-related disparities in pulmonary, critical care, and sleep","volume":"11","author":"Lyon SM","year":"2014","unstructured":"Lyon SM, Douglas IS, Cooke CR. Medicaid expansion under the Affordable Care Act. Implications for insurance-related disparities in pulmonary, critical care, and sleep. Ann Am Thorac Soc. 2014, 11:661-7. 10.1513\/AnnalsATS.201402-072PS","journal-title":"Ann Am Thorac Soc"},{"key":"ref14","article-title":"Reflections on the enactment of Medicare and Medicaid","author":"Cohen WJ","year":"1985","unstructured":"Cohen WJ. Reflections on the enactment of Medicare and Medicaid. Health Care Financ Rev. 1985, 3-11.","journal-title":"Health Care Financ Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031816-044555","article-title":"The Affordable Care Act's impacts on access to insurance and health care for low-income populations","volume":"38","author":"Kominski GF","year":"2017","unstructured":"Kominski GF, Nonzee NJ, Sorensen A. The Affordable Care Act's impacts on access to insurance and health care for low-income populations. Annu Rev Public Health. 2017, 38:489-505. 10.1146\/annurev-publhealth-031816-044555","journal-title":"Annu Rev Public Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.21653","article-title":"Association of Medicaid expansion under the Affordable Care Act with insurance status, cancer stage, and timely treatment among patients with breast, colon, and lung cancer","volume":"3","author":"Takvorian SU","year":"2020","unstructured":"Takvorian SU, Oganisian A, Mamtani R, Mitra N, Shulman LN, Bekelman JE, Werner RM. Association of Medicaid expansion under the Affordable Care Act with insurance status, cancer stage, and timely treatment among patients with breast, colon, and lung cancer. JAMA Netw Open. 2020, 3:e1921653. 10.1001\/jamanetworkopen.2019.21653","journal-title":"JAMA Netw Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002952","article-title":"Impact of the Affordable Care Act (ACA) Medicaid expansion on cancer admissions and surgeries","volume":"268","author":"Eguia E","year":"2018","unstructured":"Eguia E, Cobb AN, Kothari AN, Molefe A, Afshar M, Aranha GV, Kuo PC. Impact of the Affordable Care Act (ACA) Medicaid expansion on cancer admissions and surgeries. Ann Surg. 2018, 268:584-90. 10.1097\/SLA.0000000000002952","journal-title":"Ann Surg"},{"key":"ref18","unstructured":"SEER databases in SEER*Stat. (2024). Accessed. 2024: https:\/\/seer.cancer.gov\/data-software\/documentation\/seerstat\/."},{"key":"ref19","unstructured":"Overview of the SEER Program. (2024). Accessed. 2024: https:\/\/seer.cancer.gov\/about\/overview.html."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.18502\/ijph.v52i7.13236","article-title":"Application and use of Andersen's behavioral model as theoretical framework: a systematic literature review from 2012-2021","volume":"52","author":"Alkhawaldeh A","year":"2023","unstructured":"Alkhawaldeh A, ALashtawy M, Rayan A, et al.. Application and use of Andersen's behavioral model as theoretical framework: a systematic literature review from 2012-2021. Iran J Public Health. 2023, 52:1346-54. 10.18502\/ijph.v52i7.13236","journal-title":"Iran J Public Health"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1284784","article-title":"Uses of Andersen health services utilization framework to determine healthcare utilization for mental health among migrants-a scoping review","volume":"11","author":"Krzy\u017c EZ","year":"2023","unstructured":"Krzy\u017c EZ, Antunez Martinez OF, Lin HR. Uses of Andersen health services utilization framework to determine healthcare utilization for mental health among migrants-a scoping review. Front Public Health. 2023, 11:1284784. 10.3389\/fpubh.2023.1284784","journal-title":"Front Public Health"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.24366","article-title":"Medicaid expansion and mortality among patients with breast, lung, and colorectal cancer","volume":"3","author":"Lam MB","year":"2020","unstructured":"Lam MB, Phelan J, Orav EJ, Jha AK, Keating NL. Medicaid expansion and mortality among patients with breast, lung, and colorectal cancer. JAMA Netw Open. 2020, 3:e2024366. 10.1001\/jamanetworkopen.2020.24366","journal-title":"JAMA Netw Open"},{"key":"ref23","unstructured":"Prostate cancer survival rates. what they mean. (2024). Accessed: 2024: https:\/\/www.webmd.com\/prostate-cancer\/prostate-cancer-survival-rates-what-they-mean."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e3182467419","article-title":"Improvement in prostate cancer survival over time: a 20-year analysis","volume":"18","author":"Kim MM","year":"2012","unstructured":"Kim MM, Hoffman KE, Levy LB, et al.. Improvement in prostate cancer survival over time: a 20-year analysis. Cancer J. 2012, 18:1-8. 10.1097\/PPO.0b013e3182467419","journal-title":"Cancer J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.20034","article-title":"Early prostate cancer deaths among men with higher vs lower genetic risk","volume":"7","author":"Plym A","year":"2024","unstructured":"Plym A, Zhang Y, Stopsack KH, et al.. Early prostate cancer deaths among men with higher vs lower genetic risk. JAMA Netw Open. 2024, 7:e2420034. 10.1001\/jamanetworkopen.2024.20034","journal-title":"JAMA Netw Open"},{"key":"ref26","unstructured":"Tests to diagnose and stage prostate cancer. (2024). Accessed. 2024: https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/detection-diagnosis-staging\/how-diagnosed.html."},{"key":"ref27","unstructured":"Prostate cancer. advancements in screenings. (2024). Accessed: 2024: https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/prostate-cancer\/prostate-cancer-advancements-in-screen...."},{"key":"ref28","unstructured":"Can prostate cancer be found early?. (2024). Accessed. 2024: https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/detection-diagnosis-staging\/detection.html."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235615","article-title":"Review of current treatment intensification strategies for prostate cancer patients","volume":"15","author":"Wasim S","year":"2023","unstructured":"Wasim S, Park J, Nam S, Kim J. Review of current treatment intensification strategies for prostate cancer patients. Cancers (Basel). 2023, 15:5615. 10.3390\/cancers15235615","journal-title":"Cancers (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123133","article-title":"Innovation in radionuclide therapy for the treatment of prostate cancers: radiochemical perspective and recent therapeutic practices","volume":"15","author":"Deshayes E","year":"2023","unstructured":"Deshayes E, Fersing C, Thibault C, Roumiguie M, Pourquier P, Hou\u00e9d\u00e9 N. Innovation in radionuclide therapy for the treatment of prostate cancers: radiochemical perspective and recent therapeutic practices. Cancers (Basel). 2023, 15:3133. 10.3390\/cancers15123133","journal-title":"Cancers (Basel)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/diseases12050087","article-title":"Innovative drug modalities for the treatment of advanced prostate cancer","volume":"12","author":"Capuozzo M","year":"2024","unstructured":"Capuozzo M, Santorsola M, Ianniello M, et al.. Innovative drug modalities for the treatment of advanced prostate cancer. Diseases. 2024, 12:87. 10.3390\/diseases12050087","journal-title":"Diseases"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27984","article-title":"Multidisciplinary clinics in prostate cancer","volume":"12","author":"De B","year":"2021","unstructured":"De B, Kuban DA, Tang C. Multidisciplinary clinics in prostate cancer. Oncotarget. 2021, 12:1553-4. 10.18632\/oncotarget.27984","journal-title":"Oncotarget"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-S1-23","article-title":"The importance of supportive care in optimizing treatment outcomes of patients with advanced prostate cancer","volume":"17","author":"Scott\u00e9 F","year":"2012","unstructured":"Scott\u00e9 F. The importance of supportive care in optimizing treatment outcomes of patients with advanced prostate cancer. Oncologist. 2012, 17:23-30. 10.1634\/theoncologist.2012-S1-23","journal-title":"Oncologist"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2019.11.062","article-title":"Success of prostate and testicular cancer awareness campaigns compared to breast cancer awareness month according to internet search volumes: a Google Trends analysis","volume":"139","author":"Patel MS","year":"2020","unstructured":"Patel MS, Halpern JA, Desai AS, Keeter MK, Bennett NE, Brannigan RE. Success of prostate and testicular cancer awareness campaigns compared to breast cancer awareness month according to internet search volumes: a Google Trends analysis. Urology. 2020, 139:64-70. 10.1016\/j.urology.2019.11.062","journal-title":"Urology"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814168","article-title":"Advances in molecular medicine: unravelling disease complexity and pioneering precision healthcare","volume":"24","author":"Bustin SA","year":"2023","unstructured":"Bustin SA, Jellinger KA. Advances in molecular medicine: unravelling disease complexity and pioneering precision healthcare. Int J Mol Sci. 2023, 24:14168. 10.3390\/ijms241814168","journal-title":"Int J Mol Sci"},{"key":"ref36","unstructured":"Personalized health care. opportunities, pathways, resources. (2007). Accessed: 2024: https:\/\/www.genome.gov\/Pages\/Policy\/PersonalizedMedicine\/DHHSReportPersonalizedHealth.pdf."},{"key":"ref37","unstructured":"Prostate cancer lives as it is born. slow-growing and benign or fast-growing and dangerous. (2013). Accessed: 2024: https:\/\/www.health.harvard.edu\/blog\/prostate-cancer-lives-as-it-is-born-slow-growing-and-benign-or-fast-growing-and-d...."},{"key":"ref38","unstructured":"Prostate cancer prognosis. (2024). Accessed. 2024: https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/prostate-cancer\/prostate-cancer-prognosis."},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2016.0739","article-title":"Sharp decline in prostate cancer treatment among men in the general population, but not among diagnosed men","volume":"36","author":"Borza T","year":"2017","unstructured":"Borza T, Kaufman SR, Shahinian VB, Yan P, Miller DC, Skolarus TA, Hollenbeck BK. Sharp decline in prostate cancer treatment among men in the general population, but not among diagnosed men. Health Aff (Millwood). 2017, 36:108-15. 10.1377\/hlthaff.2016.0739","journal-title":"Health Aff (Millwood)"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.22.2713","article-title":"Natural history of early, localized prostate cancer","volume":"291","author":"Johansson JE","year":"2004","unstructured":"Johansson JE, Andr\u00e9n O, Andersson SO, Dickman PW, Holmberg L, Magnuson A, Adami HO. Natural history of early, localized prostate cancer. JAMA. 2004, 291:2713-9. 10.1001\/jama.291.22.2713","journal-title":"JAMA"},{"key":"ref41","unstructured":"Advances in prostate cancer research. (2024). Accessed. 2024: https:\/\/www.cancer.gov\/types\/prostate\/research."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1407","article-title":"Association of Medicaid expansion and insurance status, cancer stage, treatment and mortality among patients with cervical cancer","volume":"4","author":"Lee G","year":"2021","unstructured":"Lee G, Dee EC, Orav EJ, Kim DW, Nguyen PL, Wright AA, Lam MB. Association of Medicaid expansion and insurance status, cancer stage, treatment and mortality among patients with cervical cancer. Cancer Rep (Hoboken). 2021, 4:e1407. 10.1002\/cnr2.1407","journal-title":"Cancer Rep (Hoboken)"},{"key":"ref43","unstructured":"The effects of Medicaid expansion under the ACA. studies from January 2014 to January 2020. (2020). Accessed: 2024: https:\/\/www.kff.org\/medicaid\/report\/the-effects-of-medicaid-expansion-under-the-aca-updated-findings-from-a-literatur...."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.7051","article-title":"Associations of Medicaid expansion with insurance coverage, stage at diagnosis, and treatment among patients with genitourinary malignant neoplasms","volume":"4","author":"Michel KF","year":"2021","unstructured":"Michel KF, Spaulding A, Jemal A, Yabroff KR, Lee DJ, Han X. Associations of Medicaid expansion with insurance coverage, stage at diagnosis, and treatment among patients with genitourinary malignant neoplasms. JAMA Netw Open. 2021, 4:e217051. 10.1001\/jamanetworkopen.2021.7051","journal-title":"JAMA Netw Open"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.18.00147","article-title":"Hospitalization risk during chemotherapy for advanced cancer: development and validation of risk stratification models using real-world data","volume":"3","author":"Brooks GA","year":"2019","unstructured":"Brooks GA, Uno H, Aiello Bowles EJ, et al.. Hospitalization risk during chemotherapy for advanced cancer: development and validation of risk stratification models using real-world data. JCO Clin Cancer Inform. 2019, 3:1-10. 10.1200\/CCI.18.00147","journal-title":"JCO Clin Cancer Inform"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00518","article-title":"Financial toxicity in advanced and metastatic cancer: overburdened and underprepared","volume":"15","author":"Rotter J","year":"2019","unstructured":"Rotter J, Spencer JC, Wheeler SB. Financial toxicity in advanced and metastatic cancer: overburdened and underprepared. J Oncol Pract. 2019, 15:e300-7. 10.1200\/JOP.18.00518","journal-title":"J Oncol Pract"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00444-9","article-title":"Recent advances and future perspectives in the therapeutics of prostate cancer","volume":"12","author":"Varaprasad GL","year":"2023","unstructured":"Varaprasad GL, Gupta VK, Prasad K, et al.. Recent advances and future perspectives in the therapeutics of prostate cancer. Exp Hematol Oncol. 2023, 12:80. 10.1186\/s40164-023-00444-9","journal-title":"Exp Hematol Oncol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.13533","article-title":"Association of cumulative social risk and social support with receipt of chemotherapy among patients with advanced colorectal cancer","volume":"4","author":"Davis RE","year":"2021","unstructured":"Davis RE, Trickey AW, Abrahamse P, Kato I, Ward K, Morris AM. Association of cumulative social risk and social support with receipt of chemotherapy among patients with advanced colorectal cancer. JAMA Netw Open. 2021, 4:e2113533. 10.1001\/jamanetworkopen.2021.13533","journal-title":"JAMA Netw Open"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0152","article-title":"Low socioeconomic status is associated with more aggressive end-of-life care for working-age terminal cancer patients","volume":"19","author":"Chang CM","year":"2014","unstructured":"Chang CM, Wu CC, Yin WY, Juang SY, Yu CH, Lee CC. Low socioeconomic status is associated with more aggressive end-of-life care for working-age terminal cancer patients. Oncologist. 2014, 19:1241-8. 10.1634\/theoncologist.2014-0152","journal-title":"Oncologist"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2021.12.007","article-title":"Disparities in supportive care needs over time between racial and ethnic minority and non-minority patients with advanced lung cancer","volume":"63","author":"Mazor MB","year":"2022","unstructured":"Mazor MB, Li L, Morillo J, Allen OS, Wisnivesky JP, Smith CB. Disparities in supportive care needs over time between racial and ethnic minority and non-minority patients with advanced lung cancer. J Pain Symptom Manage. 2022, 63:563-71. 10.1016\/j.jpainsymman.2021.12.007","journal-title":"J Pain Symptom Manage"},{"key":"ref51","unstructured":"Black patients are more likely to die of cancer\u2014here's how one group is tackling that. (2021). Accessed. 2024: https:\/\/www.cancer.gov\/news-events\/cancer-currents-blog\/2021\/black-white-cancer-disparities-survival-accure."},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-22-0542","article-title":"AACR cancer disparities progress report 2022","volume":"31","author":"Williams PA","year":"2022","unstructured":"Williams PA, Zaidi SK, Sengupta R. AACR cancer disparities progress report 2022. Cancer Epidemiol Biomarkers Prev. 2022, 31:1249-50. 10.1158\/1055-9965.EPI-22-0542","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/324251-medicaid-expansion-and-survival-outcomes-among-men-with-prostate-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T11:12:24Z","timestamp":1736853144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/324251-medicaid-expansion-and-survival-outcomes-among-men-with-prostate-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":52,"URL":"https:\/\/doi.org\/10.7759\/cureus.77434","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.23.24315994","asserted-by":"object"}]},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,14]]}}}